The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
Protecting The Elderly From Seasonal Flu
Elderly patients could benefit from pretreatment with imiquimod before seasonal influenza vaccination.
Gene Controlling Birth Of Neurons Discovered
Scientists in Singapore have discovered an unusual gene that controls the generation of neurons in the brain.
Not Junk: lncRNA Linked To Anxiety In Mice
The long non-coding RNA Gomafu has been linked to anxiety-like behaviors and could help the brain respond to environmental changes.
Global Crop Yields Fail To Keep Pace With Demand
The world is not increasing yields of major crops quickly enough to meet future food demands from an expanding population, says a new study.
Asia’s First Under-One-Roof Nutritional Research Center Set Up In Singapore
Asia’s first under-one-roof nutritional research centre has been set up in Singapore.
Genetic Variant That Increases Lymphoma Risk In Chinese Discovered
A team of researchers has uncovered a gene variant that increases the risk of non-Hodgkin lymphoma in ethnic Chinese.
Treatment For Stomach Cancer To Be Decided By Genomic Classification Of Tumors
Researchers in Singapore have found that stomach tumors can be classified into two distinct disease variants that respond differently to chemotherapy.
It’s In The Genes: East Asians More Likely To Be Resistant To Some Cancer Drugs
A gene variant commonly found in individuals of East Asian descent, but not in African or European people, may be responsible for resistance to targeted cancer drugs used to treat certain types of leukemia and lung cancer.
3 Stomach Cancer Subtypes That Should Be Treated Differently
Stomach cancer falls into three broad subtypes that respond differently to currently available therapies, according to a new study.